HomeVINC • NASDAQ
add
Vincerx Pharma Inc
Previous close
$0.95
Day range
$0.85 - $0.95
Year range
$0.61 - $9.37
Market cap
19.28M USD
Avg Volume
1.46M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.53M | -57.57% |
Net income | -4.95M | 56.04% |
Net profit margin | — | — |
Earnings per share | -0.23 | 64.85% |
EBITDA | -5.52M | 57.62% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 12.78M | -75.63% |
Total assets | 18.22M | -69.27% |
Total liabilities | 7.00M | -39.79% |
Total equity | 11.22M | — |
Shares outstanding | 21.41M | — |
Price to book | 1.83 | — |
Return on assets | -62.18% | — |
Return on capital | -85.84% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -4.95M | 56.04% |
Cash from operations | -8.02M | 41.96% |
Cash from investing | 5.75M | 128.21% |
Cash from financing | 18.00K | -52.63% |
Net change in cash | -2.29M | 93.28% |
Free cash flow | -5.96M | 49.56% |
About
Founded
2019
Headquarters
Website
Employees
42